Grose Elysia, Xiao Jenny B, Fang Evan, Routhier-Chevrier Brigitte, Siu Jennifer M, Wolter Nikolaus E
The Hospital for Sick Children, Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada, M5G 1X8.
Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada, V6T 1Z3.
Int J Pediatr Otorhinolaryngol. 2024 Dec;187:112176. doi: 10.1016/j.ijporl.2024.112176. Epub 2024 Nov 26.
This review aims to elucidate the role of endoscopic sinus surgery (ESS) on the outcomes of pediatric patients with sinogenic intracranial infections.
MEDLINE, Embase, and the Cochrane library were searched for articles that described the outcomes in pediatric patients who had intracranial complications of acute rhinosinusitis (ARS) and underwent ESS with or without open neurosurgical approaches (ONA) or external sinus approaches (ESA). Primary outcomes of interest include mortality, revision surgery, length of stay and neurological sequelae. Random effects meta-analysis was performed.
Forty-eight articles met the final eligibility criteria, totaling 710 pediatric patients and 905 intracranial complications. The most common complications were subdural empyema (n = 261, 29 %), epidural abscess (n = 213, 24 %), and Pott's Puffy tumor (PPT) (n = 95, 10 %). When comparing patients who underwent ESS (alone or combined with ONA) to those who underwent ONA only, there was a decreased risk of revision surgery (RR = 0.66, 95 % CI = 0.38-1.12 and RR = 0.63, 95 % CI = 0.36-1.09, respectively) and decreased risk of neurological sequelae (RR = 0.65, 95 % CI = 0.15-2.74 and RR = 0.50, 95 % CI = 0.20-1.26, respectively), however these differences were not statistically significant. When patients who underwent combined intervention were compared to ESS only, the risk of revision surgery (RR = 1.04, 95 % CI = 0.62-1.72) and neurological sequelae (RR = 0.99, 95 % CI = 0.37-2.64) were similar. Risk of mortality was minimal and similar across all interventions.
The current study including primarily small retrospective studies found no statistically significant differences between children who received ESS alone, ESS with ONA or ONA alone, on mortality, revision surgery, length of stay and neurological sequelae. Although ESS may be beneficial for managing certain pediatric sinogenic intracranial infections, its true effectiveness is difficult to determine due to the variability in the types of intracranial complications and the inconsistent extent of ESS procedures reported in the literature.
本综述旨在阐明鼻内镜鼻窦手术(ESS)在患有鼻窦源性颅内感染的儿科患者治疗结果中的作用。
检索MEDLINE、Embase和Cochrane图书馆,查找描述患有急性鼻窦炎(ARS)颅内并发症并接受ESS联合或不联合开放性神经外科手术(ONA)或外部鼻窦手术(ESA)的儿科患者治疗结果的文章。主要关注的结果包括死亡率、翻修手术、住院时间和神经后遗症。进行随机效应荟萃分析。
48篇文章符合最终纳入标准,共计710例儿科患者和905例颅内并发症。最常见的并发症是硬膜下积脓(n = 261,29%)、硬膜外脓肿(n = 213,24%)和波特氏浮肿性肿瘤(PPT)(n = 95,10%)。将接受ESS(单独或联合ONA)的患者与仅接受ONA的患者进行比较时,翻修手术风险降低(RR = 0.66,95% CI = 0.38 - 1.12和RR = 0.63,95% CI = 0.36 - 1.09),神经后遗症风险降低(RR = 0.65,95% CI = 0.15 - 2.74和RR = 0.50,95% CI = 0.20 - 1.26),然而这些差异无统计学意义。将接受联合干预的患者与仅接受ESS的患者进行比较时,翻修手术风险(RR = 1.04,95% CI = 0.62 - 1.72)和神经后遗症风险(RR = 0.99,95% CI = 0.37 - 2.64)相似。所有干预措施的死亡率风险都很低且相似。
当前研究主要包括小型回顾性研究,结果发现单独接受ESS、ESS联合ONA或仅接受ONA的儿童在死亡率、翻修手术、住院时间和神经后遗症方面无统计学显著差异。尽管ESS可能有助于治疗某些儿科鼻窦源性颅内感染,但由于颅内并发症类型的变异性以及文献中报道的ESS手术范围不一致,其真正效果难以确定。